Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 12, Pages 3541
Publisher
MDPI AG
Online
2020-11-27
DOI
10.3390/cancers12123541
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The hTERT core promoter forms three parallel G-quadruplexes
- (2020) Robert C Monsen et al. NUCLEIC ACIDS RESEARCH
- Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study
- (2020) Md Ismail Hosen et al. EBioMedicine
- Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes
- (2020) Joshua J. Meeks et al. Nature Reviews Urology
- Monitoring of urothelial cancer disease status after treatment by digital droplet PCR liquid biopsy assays
- (2020) John J.G. Pritchard et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer
- (2020) Maria Zvereva et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The prevalence of bladder cancer during cystoscopy for asymptomatic microscopic hematuria
- (2019) Ashley N Gonzalez et al. UROLOGY
- Diagnostic potential of TERT promoter and FGFR 3 mutations in urinary cell‐free DNA in upper tract urothelial carcinoma
- (2019) Yujiro Hayashi et al. CANCER SCIENCE
- Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer
- (2019) Patrice Hodonou Avogbe et al. EBioMedicine
- Liquid biopsy in the clinical management of bladder cancer: current status and future developments
- (2019) Erik Kouba et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Clinical utility versus futility: a tipping point for liquid biopsies in bladder cancer
- (2019) Erik Kouba et al. Future Oncology
- Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer
- (2019) Uttam Satyal et al. Frontiers in Oncology
- Optimizing Amplification of the GC-RichTERTPromoter Region Using 7-Deaza-dGTP for Droplet Digital PCR Quantification ofTERTPromoter Mutations
- (2018) Andrew J. Colebatch et al. CLINICAL CHEMISTRY
- Droplet Digital PCR for Mutation Detection in Formalin-Fixed, Paraffin-Embedded Melanoma Tissues
- (2018) Ashleigh C. McEvoy et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Urinary cell-free DNA is a versatile analyte for monitoring infections of the urinary tract
- (2018) Philip Burnham et al. Nature Communications
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants
- (2018) Joshua I. Warrick et al. EUROPEAN UROLOGY
- Development of Novel Mutation-Specific Droplet Digital PCR Assays Detecting TERT Promoter Mutations in Tumor and Plasma Samples
- (2018) Broderick Corless et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer
- (2017) Emil Christensen et al. EUROPEAN UROLOGY
- Current and Emerging Applications of Droplet Digital PCR in Oncology
- (2017) Susana Olmedillas-López et al. Molecular Diagnosis & Therapy
- Sensitive droplet digital PCR method for detection of TERT promoter mutations in cell free DNA from patients with metastatic melanoma
- (2017) Ashleigh C. McEvoy et al. Oncotarget
- Mutations inTERTpromoter andFGFR3and telomere length in bladder cancer
- (2015) Ismail Hosen et al. INTERNATIONAL JOURNAL OF CANCER
- Quantitative Cell-Free Circulating BRAFV600E Mutation Analysis by Use of Droplet Digital PCR in the Follow-up of Patients with Melanoma Being Treated with BRAF Inhibitors
- (2014) M. F. Sanmamed et al. CLINICAL CHEMISTRY
- The Health Economics of Bladder Cancer: An Updated Review of the Published Literature
- (2014) Christina Yeung et al. PHARMACOECONOMICS
- TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine
- (2013) I. Kinde et al. CANCER RESEARCH
- Urine markers for detection and surveillance of bladder cancer
- (2013) Evanguelos Xylinas et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic
- (2011) Christopher G.T. Blick et al. BJU INTERNATIONAL
- Self-organization of G-quadruplex structures in the hTERT core promoter stabilized by polyaminic side chain perylene derivatives
- (2010) Emanuela Micheli et al. BIOPHYSICAL CHEMISTRY
- The Shortest Clopper–Pearson Confidence Interval for Binomial Probability
- (2009) Wojciech Zieliński COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search